HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Does hemodiafiltration improve the removal of homocysteine?

Abstract
High prevalence of hyperhomocysteinemia is common in hemodialysis (HD) patients and could contribute to worsen the cardiovascular risk. Beyond vitamin B status, dialysis modality itself could influence homocysteine (Hcy) levels. The objective was compare the reduction rate (RR) of Hcy and cysteine in stable dialyzed patients treated by standard HD or hemodiafiltration (HDF). Seventy-five patients undergoing stable dialysis through standard high-flux HD (n = 35) or HDF (n = 40) were included. Biological parameters were determined before and after a midweek dialysis session. Urea percent reduction per session and Kt/V index (K, body urea clearance, T, time of dialysis, and V, urea distribution volume), defined as a marker of dialysis efficacy, were similar between HD and HDF groups. By contrast, higher RR of beta2 microglobulin (β2m) was observed in HDF compared with HD (78.6 vs. 72.0%, respectively; P < 0.001). Likewise, higher RR of Hcy was obtained with HDF compared to HD (46.0 vs. 41.5%, respectively; P < 0.05), whereas the RR of cysteine was similar in both groups. Interestingly, a positive correlation between Hcy RR and urea Kt/V index was observed (r = 0.29, P < 0.05) and between Hcy RR and β2m RR (r = 0.45, P < 0.001). Time-averaged concentration (TAC) of Hcy was lower with HDF compared with HD (17.8 vs. 19.1 μmol/L, respectively), although not significant. There was no difference in median Hcy according to dialysis modality for neither pre- nor postdialysis levels. Significant higher removal of Hcy was observed with HDF compared with standard HD, although urea Kt/V index was similar. Enhanced removal of middle molecules, such as β2m, could be involved in Hcy RR improvement with HDF.
AuthorsStéphanie Badiou, Marion Morena, Anne-Sophie Bargnoux, Isabelle Jaussent, Annie Rodriguez, Helene Leray-Moragues, Lofti Chalabi, Jean-Yves Bosc, Bernard Canaud, Jean-Paul Cristol
JournalHemodialysis international. International Symposium on Home Hemodialysis (Hemodial Int) Vol. 15 Issue 4 Pg. 515-21 (Oct 2011) ISSN: 1542-4758 [Electronic] Canada
PMID22111820 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study)
Copyright© 2011 The Authors; Hemodialysis International © 2011 International Society for Hemodialysis.
Chemical References
  • beta 2-Microglobulin
  • Homocysteine
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Cardiovascular Diseases (blood, etiology)
  • Cross-Sectional Studies
  • Female
  • Hemodiafiltration
  • Homocysteine (blood)
  • Humans
  • Hyperhomocysteinemia (blood, etiology, therapy)
  • Kidney Failure, Chronic (blood, therapy)
  • Male
  • Middle Aged
  • Risk Factors
  • beta 2-Microglobulin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: